Roundtable Discussion: Discovering Genetic Predispositions for Personalized Intervention Strategies to Identify High-Risk Individuals for Preventative & Targeted Treatments
- Utilizing polygenic risk scores for assessing individual susceptibility to predict obesity development for early intervention strategies
- Identifying monogenic obesity genes for precise diagnosis and treatment selection to enable targeted therapies for improved patient outcomes
- Applying pharmacogenomics for predicting drug response and side effect profiles to personalize medication choices for optimized therapeutic efficacy and safety